Marta Castroviejo‐Bermejo
0000-0002-8540-5837
Publication & Citation Trends
Publications
0 total
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance OA
Cited by 35
Semantic Scholar
1O Detection of homologous recombination repair deficiency (HRD) in treatment-naive early triple-negative breast cancer (TNBC) by RAD51 foci and comparison with DNA-based tests OA
Cited by 5
Semantic Scholar
Abstract 932: Reversing PARP inhibitor resistance by targeting the replication stress response
Cited by 1
Semantic Scholar
A decade of clinical development of PARP inhibitors in perspective OA
Cited by 598
Semantic Scholar
Abstract 3503: Biomarkers for inhibitors of the replication stress response proteins WEE1 and ATR in triple negative breast cancer
Cited by 0
Semantic Scholar
Alternative transcript imbalance underlying breast cancer susceptibility in a family carrying PALB2 c.3201+5G>T
Cited by 7
Semantic Scholar
Abstract P6-06-03: Withdrawn
Cited by 0
Semantic Scholar
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer OA
Cited by 372
Semantic Scholar
Research Topics
CRISPR and Genetic Engineering
(16)
PARP inhibition in cancer therapy
(11)
DNA Repair Mechanisms
(10)
BRCA gene mutations in cancer
(3)
RNA and protein synthesis mechanisms
(2)
Affiliations
Vall d'Hebron Institut de Recerca
Vall d'Hebron Hospital Universitari
Vall d'Hebron Institute of Oncology